The effects of body condition score of does and exposure to sexually active bucks after exposure to long-day artificial photoperiod were examined in mature anovulatory French Alpine goat in Northern Mexico. In June, goats in good (2.3 +/- 0.2, scale 1 to 4; n = 10) or poor (1.6 +/- 0.3; n = 10) body condition were exposed during 15 day to sexually active bucks, which had been exposed to long photoperiod (16:8-h light-dark cycle, starting in December). A third group of goats in good body condition was exposed to bucks kept under the natural photoperiod of this region (26 degrees N). All goats in good body condition exposed to bucks treated with prolonged photoperiod exhibited estrus behavior, whereas only 50% of the does in poor body condition showed estrous behavior during the 15-day buck exposure. None of the does in good body condition showed estrus when exposed to bucks under natural photoperiod. These results revealed that a good body condition is required for maximum estrus response in anestrous Alpine goats and that exposure of bucks to long photoperiod in winter is essential for an adequate stimulus to reestablish estrus cycles in anovulatory Alpine does in Northern Mexico.
Establishment of the hypothalamic-hypophyseal-gonadal function is dependent on the highly controlled and dynamic interactions between regulatory signals from the brain, pituitary and gonads, all of them leading to the attainment of reproductive capacity, where a coordinated and timely activation of GnRH neurons must occur. The GnRH neurons extend their neurosecretory axons to the hypothalamus where GnRH is released into the pituitary portal vessels to elicit the secretion of LH and FSH, which in turn, will promote gonadal development and support reproductive physiology. Genetic studies have demonstrated that disabling mutations and targeted deletions of the G-protein-coupled receptor (GPR54) generated hypogonadotropic hypogonadism. This link between GPR54 and reproduction, generated attention to the natural ligands of the GPR54 receptor, known as kisspeptins, which are translational products of the hypothalamic gene KiSS1. Recent advances in kisspeptin research have defined a major role of this molecule in controlling the onset of the reproductive function observed at puberty. The aim of this review is to highlight the basic endocrine and genetic concepts involved in the establishment of the hypothalamic-hypophyseal-gonadal axis function which promotes the onset of the reproductive function during puberty. The review highlights what is currently known about the kisspeptin-GPR54 signalling system in the activation of the GnRH neurons.
The effect of beta-carotene supplementation upon luteal activity, measured as number (CLT) and volume (VLT) of corpus luteum, and P4 synthesis in goats, was evaluated. Goats (n = 22, 34 months) were randomly assigned to one of two experimental groups: (i) beta-carotene [Beta, n = 10; body weight (BW = 44.8 +/- 1.45 kg), body condition score (BCS = 3.25 +/- 0.07)], and (ii) Control (Control, n = 12; BW = 45.30 +/- 1.32 kg, BCS = 3.33 +/- 0.06). Upon oestrus synchronization, the Beta group received 50 mg of beta-carotene per day during 35 days pre- and 17 days post-ovulation. The day 4, 8, 12 and 16 post-ovulation, blood samples were collected for quantification of serum P4 concentrations by radioimmmunoassay, and transrectal ultrasonographic scanning was performed at day 18 for evaluating CLT and VLT. Overall, CLT and VLT mean were 3.10 and 2211.1 mm(3) respectively. The Beta-goats depicted both the largest values for CLT (p = 0.07) and serum P4 levels (p = 0.05), with no differences (p = 0.53) for VLT between treatments. Results suggest a higher efficiency within the cellular-enzymatic groups defining the steroidogenic pathways in the beta-carotene-supplemented goats, generating a larger P4 synthesis. The last is essential for ovulation of healthy oocytes, maintenance of uterine quiescence, nourishment and survival of the embryo around implantation; all of them of paramount significance during the maternal recognition of pregnancy process.
Durante el verano del 2002 la colecta de polen y la distribución de las abejas (Apis mellifera L.) pecoreadoras fueron estudiadas en el cultivo de melón (Cucumis melo L., cv Cruiser ) bajo condiciones de riego por goteo y acolchado plástico. El lote experimental estuvo localizado cerca del Campo Experimental La Laguna del INIFAP, en el municipio de Matamoros, Coahuila, México. Dos experimentos se realizaron en el mismo predio, en lotes separados 800 m por una huerta de nogal. Ambas superficies de melón fueron sembradas en la misma fecha. Experimento N° 1. Al inicio de la floración se colocaron nueve colmenas en tres hectáreas de cultivo. Cada colmena contó con una trampa de polen tipo Ontario modificada. El polen se colectó cada hora de cada colmena un día por semana de las 8:30 hr a las 14:30 hr durante las cuatro primeras semanas de floración del cultivo. Experimento N° 2. Tres semanas después del inicio de la floración se colocaron 30 colmenas en un campo de melón de diez hectáreas. En cuatro surcos de 105 m de longitud se marcaron transectos de diez metros a 25, 50, 75 y 100 metros de distancia del apiario. Las abejas pecoreadoras fueron contadas simultáneamente en cada transecto cada media hora de las 7:30 hr hasta las 20:30 horas, el mismo día en que fue colectado el polen de la tercera semana de floración. La colecta de polen fue mayor temprano por la mañana (22.6 g por colmena), disminuyendo a una cantidad media de las 9:30 hr (13.7 g), 10:30 hr (12.5 g) a las 11:30 hr (9.5 g) y permaneciendo baja desde las 12:30 hasta el mediodía (menos de 2.6 g por colmena; p<0.05). El patrón de distribución mostró que las abejas se presentaron en el cultivo de melón después de las 8:00 hr y alcanzaron su máximo entre las 10:30 hr y las 14:30 hr cuando las abejas iniciaron su disminución hasta el cese de los vuelos a las 20:30 hr. No se encontraron diferencias significativas en el número de abejas pecoreadoras a las diferentes distancias del apiario que fueron evaluadas.
The objective of this study was to evaluate the efficacy of treating sexually inactive bucks with artificial long photoperiod or testosterone on the induction of estrus in anovulatory grazing goats. A total of 91 multiparous mixed-breed anestrous goats were randomly assigned to one of three treatment groups: (1) joining with bucks subjected to 2.5 month of artificial long days (16 h of light/day; n=31), (2) joining with testosterone-treated bucks (n=30), and (3) joining with untreated bucks (control; n=30). There were no differences between the light-treated (100%) and testosterone-treated (93%) bucks in their ability to induce estrus in anovulatory does. On the other hand, none of the goats in contact with control bucks exhibited estrus. The interval from start of mating to estrus was shorter in goats with the light-treated bucks (37.9 ± 4.8 h) compared with does in contact with testosterone-treated bucks (58.3 ± 8.7 h). The overall pregnancy rate in goats joined with light-treated, testosterone-treated and control bucks was 84%, 77% and 0%, respectively, with no difference (P>0.05) between the first two groups. Anogenital sniffing, approaches, mounting attempts, and mounts were highest (P<0.01) in light-treated bucks and lowest in control bucks. It was concluded that testosterone-treated bucks and long-day-treated bucks were equally effective in synchronizing estrus in anovulatory goats and resulted in similar levels of fertility. Given that light-treated bucks are unviable in communal production systems of goats raised by resource-poor farmers, the sexual arousal of bucks with testosterone is a practical and reliable method to induce ovulation in anovulatory goats in pastoral goat systems in hot environments.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.